Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBITDA (2016 - 2025)

Historic EBITDA for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $34.6 million.

  • Innoviva's EBITDA fell 2002.68% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 2036.32%. This contributed to the annual value of $7.8 million for FY2024, which is 8074.46% down from last year.
  • Innoviva's EBITDA amounted to $34.6 million in Q3 2025, which was down 2002.68% from $48.8 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's EBITDA registered a high of $96.5 million during Q2 2021, and its lowest value of -$11.3 million during Q1 2023.
  • Moreover, its 5-year median value for EBITDA was -$6.0 million (2021), whereas its average is $18.5 million.
  • As far as peak fluctuations go, Innoviva's EBITDA tumbled by 10955.04% in 2022, and later soared by 151530000.0% in 2023.
  • Quarter analysis of 5 years shows Innoviva's EBITDA stood at -$6.0 million in 2021, then crashed by 70.77% to -$10.3 million in 2022, then surged by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then surged by 428.1% to $34.6 million in 2025.
  • Its last three reported values are $34.6 million in Q3 2025, $48.8 million for Q2 2025, and -$8.2 million during Q1 2025.